FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996044510> ?p ?o ?g. }

• W1996044510 endingPage "271" @default.
• W1996044510 startingPage "265" @default.
• W1996044510 abstract "Objective: This study was conducted to evaluate once-weekly liposomal amphotericin B (L-AmB) for Candida prophylaxis in very low birth weight (VLBW) neonates. Methods: This prospective, randomized, open-label, placebo-controlled study included neonates who were <32 weeks’ gestational age, <7 days old, and weighing <1500 g at birth. Subjects were randomized to receive L-AmB 5 mg/kg per week or placebo (dextrose water) and were followed until 6 weeks of age. Surveillance cultures were obtained at baseline, at 72 hours, and weekly thereafter. Study drug was continued until 6 weeks after birth or the discontinuation of high-risk treatments and invasive devices, whichever occurred first. Blood cultures were obtained as clinically indicated. The primary end point was development of Candida colonization by 6 weeks’ postnatal age; secondary end points included development of invasive candidiasis and occurrence of treatment-related adverse events. Safety variables included renal and hepatic function tests, incidence of grade III–IV intraventricular hemorrhage (IVH) and necrotizing enterocolitis (NEC), and mortality. Results: Forty subjects were enrolled and randomized to receive L-AmB (12 males, 8 females; 50% white) or placebo (12 males, 8 females; 35% white). Subjects were evenly distributed by gestational age, age at enrollment, birth weight, race, and sex. Consent was withdrawn after completion of study treatment in 1 subject (L-AmB); 1 subject in each study arm died during the study; and 3 subjects were transferred back to their referring institutions (1 L-AmB, 2 placebo). Thus, 17 subjects in each arm completed all study procedures, although all 40 subjects were evaluable. Colonization before administration of study drug was noted in 4 L-AmB subjects (20%) and 1 placebo subject (5%); 1 (5%) and 3 (15%) subjects in the respective groups developed colonization while receiving study drug. No L-AmB subjects and 1 placebo subject developed candidiasis. One subject in each group died; these deaths were not considered related to study drug or fungal infection. There were no clinical differences between groups in the incidence of grade III–IV IVH, NEC, hypokalemia, nephrotoxicity, need for platelet or packed red blood cell transfusion, or mortality. Conclusions: L-AmB 5 mg/kg once weekly was generally well tolerated in these VLBW infants. The data did not allow evaluation of efficacy. A larger, multicenter, randomized clinical trial of L-AmB for Candida prophylaxis that is appropriately powered is warranted." @default.
• W1996044510 created "2016-06-24" @default.
• W1996044510 creator A5017863476 @default.
• W1996044510 creator A5019622788 @default.
• W1996044510 creator A5039479809 @default.
• W1996044510 creator A5041103599 @default.
• W1996044510 creator A5041606755 @default.
• W1996044510 creator A5049736360 @default.
• W1996044510 creator A5066765938 @default.
• W1996044510 creator A5068675398 @default.
• W1996044510 creator A5078067277 @default.
• W1996044510 date "2010-02-01" @default.
• W1996044510 modified "2023-09-27" @default.
• W1996044510 title "Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: A prospective, randomized, open-label, placebo-controlled pilot study" @default.
• W1996044510 cites W1551302926 @default.
• W1996044510 cites W1966569663 @default.
• W1996044510 cites W1969659982 @default.
• W1996044510 cites W1970328266 @default.
• W1996044510 cites W1982789371 @default.
• W1996044510 cites W1984081181 @default.
• W1996044510 cites W1989728928 @default.
• W1996044510 cites W2005530044 @default.
• W1996044510 cites W2014404540 @default.
• W1996044510 cites W2016673581 @default.
• W1996044510 cites W2017046795 @default.
• W1996044510 cites W2030580513 @default.
• W1996044510 cites W2033920127 @default.
• W1996044510 cites W2036887186 @default.
• W1996044510 cites W2039413289 @default.
• W1996044510 cites W2051411729 @default.
• W1996044510 cites W2061186719 @default.
• W1996044510 cites W2065720593 @default.
• W1996044510 cites W2070088559 @default.
• W1996044510 cites W2075517361 @default.
• W1996044510 cites W2082201571 @default.
• W1996044510 cites W2087405104 @default.
• W1996044510 cites W2087603985 @default.
• W1996044510 cites W2089901750 @default.
• W1996044510 cites W2096283311 @default.
• W1996044510 cites W2130699530 @default.
• W1996044510 cites W2132554040 @default.
• W1996044510 cites W2143687882 @default.
• W1996044510 cites W2147980015 @default.
• W1996044510 cites W2150428940 @default.
• W1996044510 cites W2333825775 @default.
• W1996044510 doi "https://doi.org/10.1016/j.clinthera.2010.02.016" @default.
• W1996044510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20206784" @default.
• W1996044510 hasPublicationYear "2010" @default.
• W1996044510 type Work @default.
• W1996044510 sameAs 1996044510 @default.
• W1996044510 citedByCount "21" @default.
• W1996044510 countsByYear W19960445102012 @default.
• W1996044510 countsByYear W19960445102013 @default.
• W1996044510 countsByYear W19960445102014 @default.
• W1996044510 countsByYear W19960445102015 @default.
• W1996044510 countsByYear W19960445102017 @default.
• W1996044510 countsByYear W19960445102018 @default.
• W1996044510 countsByYear W19960445102019 @default.
• W1996044510 countsByYear W19960445102021 @default.
• W1996044510 countsByYear W19960445102022 @default.
• W1996044510 crossrefType "journal-article" @default.
• W1996044510 hasAuthorship W1996044510A5017863476 @default.
• W1996044510 hasAuthorship W1996044510A5019622788 @default.
• W1996044510 hasAuthorship W1996044510A5039479809 @default.
• W1996044510 hasAuthorship W1996044510A5041103599 @default.
• W1996044510 hasAuthorship W1996044510A5041606755 @default.
• W1996044510 hasAuthorship W1996044510A5049736360 @default.
• W1996044510 hasAuthorship W1996044510A5066765938 @default.
• W1996044510 hasAuthorship W1996044510A5068675398 @default.
• W1996044510 hasAuthorship W1996044510A5078067277 @default.
• W1996044510 hasConcept C126322002 @default.
• W1996044510 hasConcept C141071460 @default.
• W1996044510 hasConcept C142724271 @default.
• W1996044510 hasConcept C168563851 @default.
• W1996044510 hasConcept C187212893 @default.
• W1996044510 hasConcept C197934379 @default.
• W1996044510 hasConcept C204787440 @default.
• W1996044510 hasConcept C27081682 @default.
• W1996044510 hasConcept C2778376644 @default.
• W1996044510 hasConcept C2778715236 @default.
• W1996044510 hasConcept C2779234561 @default.
• W1996044510 hasConcept C2779252433 @default.
• W1996044510 hasConcept C2779303187 @default.
• W1996044510 hasConcept C54355233 @default.
• W1996044510 hasConcept C66322754 @default.
• W1996044510 hasConcept C71924100 @default.
• W1996044510 hasConcept C86803240 @default.
• W1996044510 hasConceptScore W1996044510C126322002 @default.
• W1996044510 hasConceptScore W1996044510C141071460 @default.
• W1996044510 hasConceptScore W1996044510C142724271 @default.
• W1996044510 hasConceptScore W1996044510C168563851 @default.
• W1996044510 hasConceptScore W1996044510C187212893 @default.
• W1996044510 hasConceptScore W1996044510C197934379 @default.
• W1996044510 hasConceptScore W1996044510C204787440 @default.
• W1996044510 hasConceptScore W1996044510C27081682 @default.
• W1996044510 hasConceptScore W1996044510C2778376644 @default.
• W1996044510 hasConceptScore W1996044510C2778715236 @default.
• W1996044510 hasConceptScore W1996044510C2779234561 @default.

• next